Skip to main content
Clinical Trials/ACTRN12606000318583
ACTRN12606000318583
Completed
Phase 3

A multicentred randomised controlled trial of repeat doses of prenatal corticosteroid given to women who remain at risk of preterm delivery for the prevention of neonatal morbidity.

Professor Caroline Crowther0 sites980 target enrollmentMarch 5, 2001

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Women at risk of preterm birth, at less than 32 weeks gestation, who have already received a course of prenatal corticosteroids.
Sponsor
Professor Caroline Crowther
Enrollment
980
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 5, 2001
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Professor Caroline Crowther

Eligibility Criteria

Inclusion Criteria

  • Singleton, twin or triplet pregnancy; \<32 weeks gestation; \> or \= 7 days since first corticosteroid treatment, remaining at risk of preterm delivery; informed written signed consent given.

Exclusion Criteria

  • Women with chrioamnionitis requiring urgent delivery; Women in whom L/S ratio or equivalent test is judged mature; Women in 2nd stage labour; Women in whom corticosteroid therapy is considered essential.

Outcomes

Primary Outcomes

Not specified

Similar Trials